DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Lomitapide

Lomitapide

  • Homozygous Familial Hypercholesterolemia - Juxtapid® (Lomitapide Capsules)

    Homozygous Familial Hypercholesterolemia - Juxtapid® (Lomitapide Capsules)

  • Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1

    Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1

  • Annexes of the Annual Report 2011

    Annexes of the Annual Report 2011

  • Clinical Policy: Lomitapide (Juxtapid) Reference Number: ERX.SPA.170 Effective Date: 01.11.17 Last Review Date: 11.17 Revision Log

    Clinical Policy: Lomitapide (Juxtapid) Reference Number: ERX.SPA.170 Effective Date: 01.11.17 Last Review Date: 11.17 Revision Log

  • Bempedoic Acid

    Bempedoic Acid

  • Juxtapid (Lomitapide)

    Juxtapid (Lomitapide)

  • Lomitapide for Treating Homozygous Familial Hypercholesterolaemia (Adults)

    Lomitapide for Treating Homozygous Familial Hypercholesterolaemia (Adults)

  • Juxtapid® (Lomitapide) P&T Approval Date 10/2015, 9/2016, 9/2017, 9/2018, 9/2019, 9/2020 Effective Date 12/1/2020; Oxford: N/A

    Juxtapid® (Lomitapide) P&T Approval Date 10/2015, 9/2016, 9/2017, 9/2018, 9/2019, 9/2020 Effective Date 12/1/2020; Oxford: N/A

  • Lojuxta, INN-Lomitapide

    Lojuxta, INN-Lomitapide

  • Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs

    Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs

  • Study Protocol 1002-046 Amendment 1, 10 April 2017

    Study Protocol 1002-046 Amendment 1, 10 April 2017

  • Lipotropics, Other

    Lipotropics, Other

  • Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018

    Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018

  • Juxtapid (Lomitapide)

    Juxtapid (Lomitapide)

  • Lojuxta, INN-Lomitapide

    Lojuxta, INN-Lomitapide

  • WO 2016/066256 Al 6 May 2016 (06.05.2016) W P O P C T

    WO 2016/066256 Al 6 May 2016 (06.05.2016) W P O P C T

  • And Bempedoic Acid/Ezetimibe (Nexlizet™) New Drug Update

    And Bempedoic Acid/Ezetimibe (Nexlizet™) New Drug Update

  • Juxtapid) Reference Number: CP.PHAR.283 Effective Date: 10.01.16 Last Review Date: 02.20 Revision Log Line of Business: Commercial, Medicaid

    Juxtapid) Reference Number: CP.PHAR.283 Effective Date: 10.01.16 Last Review Date: 02.20 Revision Log Line of Business: Commercial, Medicaid

Top View
  • Severe Hypertriglyceridemia with Pancreatitisthirteen Years
  • Lomitapide (Juxtapid) Reference Number: PA.CP.PHAR.283 Effective Date: 01/18 Last Review Date: 10/17 Revision Log Line of Business: Medicaid
  • Juxtapid (Lomitapide) MCP-155
  • Study Protocol 1002-048 Amendment 2, 10 February 2017
  • 211616Orig1s000
  • Juxtapid® (Lomitapide) Capsules Annual Review Date: 05/20/2021
  • WO 2015/167760 Al 5 November 2015 (05.11.2015) P O P C T
  • Bile Acid Sequestrants • Niacin • Fibrates • Mipomersen • Lomitapide • LDL Apheresis Evidence for Treating All FH Patients
  • Bempedoic Acid and Inclisiran for Patients with Heterozygous Familial Hypercholesterolemia and for Secondary Prevention of ASCVD: Effectiveness and Value
  • 2020 Annual Report Will Be Remembered As the Year Everything Changed
  • Lomitapide (Juxtapid®)
  • JUXTAPID (Lomitapide)
  • ATC 2016.Xlsx
  • Treating Homozygous Familial Hypercholesterolemia in a Real-World Setting: Experiences with Lomitapide
  • Lomitapide (Juxtapid) Reference Number: ERX.SPMN.185 Effective Date: 01/2017 Revision Log Last Review Date
  • JUXTAPID (Lomitapide)
  • Trends in Lipid-Modifying Agent Use in 83 Countries
  • Juxtapid Lomitapide MCP


© 2024 Docslib.org    Feedback